Article

Essilor names new VP, brings French art to Dallas

Dallas-Essilor of America has named Carl Bracy as vice president of marketing. Bracy, who previously was senior vice president of retail markets for TXU Corp., a Dallas energy company, will be responsible for introducing Essilor products and services to the marketplace.

Dallas-Essilor of America has named Carl Bracy as vice president of marketing. Bracy, who previously was senior vice president of retail markets for TXU Corp., a Dallas energy company, will be responsible for introducing Essilor products and services to the marketplace.

Meanwhile, the company is bringing to its local headquarters a taste of its France-based parent company.

Essilor of America is sponsoring an exhibition of 70 iconic works by the masters of French 19th century art at the Dallas Museum of Art. The show, called "Bonjour, Monsieur Courbet! The Bruyas Collection of the Musee Fabre, Montpellier," will be on display through early January.

"The viewing of the paintings, drawings, and sculptures from this beautiful period is a subtle reminder as to why our company's mission is all about vision," said Hubert Sagnieres, president of Essilor of America.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.